about
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates. It combines an understanding of target biology with protein engineering, proprietary discovery technologies, and an integ...
Read More
109.35
4.62
(4.41%)
483.4K
XNAS Volume
XNAS 18 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Inhibrx Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..